Men | Women | |||
---|---|---|---|---|
Unadjusted RRR (%CI) | Adjusted RRR (%CI) | Unadjusted RRR (%CI) | Adjusted RRR (%CI) | |
Poor QoL vs. good/neutral QoL | ||||
Age | 1.0 (1.0–1.0) | 1.0 (1.0–1.0) | 1.0 (1.0–1.0) | 1.0 (1.0–1.1) |
Clinical anxiety symptoms | 1.0 (0.6–1.7) | 0.7 (0.4–1.3) | 1.8 (0.8–4.4) | 0.9 (0.3–2.7) |
Clinical depression symptoms | 1.3 (0.7–2.2) | 1.4 (0.7–2.6) | 3.0 (1.2–7.5)** | 3.3 (1.0–10.3)* |
Physically inactive | 1.9 (1.1–3.1)** | 1.6 (0.9–2.8) a | ----- | ----- |
Weight evaluation (reference: satisfied) | ||||
Considers self underweight | 2.0 (1.1–3.6)** | 2.0 (1.0–3.9)* | ----- | ----- |
Considers self overweight | 2.2 (1.1–4.5)** | 2.0 (0.9–3.9) a | ----- | ----- |
Eats meals alone | 1.4 (0.8–2.3) | 1.5 (0.9–2.7) | ----- | ----- |
Social network (reference: no network) | ----- | ----- | ||
Substance-free | 1.0 (0.5–2.2) | 1.5 (0.6–3.4) | ----- | ----- |
Substance-using | 1.0 (0.5–2.1) | 1.1 (0.5–2.6) | ----- | ----- |
Substance user category (reference: polysubstance user) | ||||
Prescribed OMT and/or medications only | ----- | ----- | 0.0 (-)b | ----- |
Substance- and medication-free | ----- | ----- | 0.0 (-)b | ----- |
Single-substance user | ----- | ----- | 0.4 (0.1–2.2) | ----- |
Most used substance: methadone/buprenorphine | 0.6 (0.3–1.0) a | 0.5 (0.3–0.9)* | 0.4 (0.2–1.8) | 0.6 (0.2–1.7) |
Very poor QoL vs. good/neutral QoL | ||||
Age | 1.0 (1.0–1.0) | 1.0 (0.9–1.0) | 1.0 (0.9–1.0) | 1.0 (1.0–1.1) |
Clinical anxiety symptoms | 2.3 (1.3–4.0)** | 1.4 (0.7–2.9) | 3.1 (1.3–7.5)** | 1.3 (0.4–3.8) |
Clinical depression symptoms | 2.3 (1.3–3.9)** | 1.5 (0.8–3.1) | 4.4 (1.8–10.8)** | 3.8 (1.2–11.8)* |
Physically inactive | 2.0 (1.6–3.4)** | 2.0 (1.1–3.7)* | ||
Weight evaluation (reference: satisfied) | ||||
Considers self underweight | 2.0 (1.0–3.8) | 2.0 (1.1–3.7)* | ----- | ----- |
Considers self overweight | 2.0 (1.0–4.1) | 1.6 (0.7–3.6) | ----- | ----- |
Eats meals alone | 2.7 (1.6–4.8)*** | 2.6 (1.4–4.8)* | ----- | ----- |
Social network (reference: no network) | ||||
Substance-free | 0.4 (0.2–0.9)** | 0.7 (0.3–1.7) | ----- | ----- |
Substance-using | 0.7 (0.3–1.3) | 0.9 (0.4–2.1) | ----- | ----- |
Substance user category (reference: polysubstance user) | ||||
Prescribed OMT and/or medications only | ----- | ----- | 0.0 (-)b | ----- |
Substance- and medication-free | ----- | ----- | 0.0 (-)b | ----- |
Single-substance user | ----- | ----- | 0.6 (0.1–2.6) | ----- |
Most used substance: methadone/buprenorphine | 0.5 (0.2–0.8)* | 0.4 (0.2–0.9)* | 0.2 (0.0–0.6)* | 0.2 (0.0–0.6)* |